Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Vortioxetine Hydrobromide Tablets

Approval Number

国药准字H20243148

Company辰欣药业股份有限公司

Registration Date

February 6, 2024

Drug Information

Generic Name

氢溴酸伏硫西汀片

Dosage Form

片剂

Strength

5mg（以C₁₈H₂₂N₂S计）

Drug Type

化学药品

Registration Date

February 6, 2024

Company Information

Applicant Company

Company Name辰欣药业股份有限公司

Company Address

济宁高新区同济科技工业园

Manufacturing Company

Company Name广州玻思韬控释药业有限公司

Company Address

广州市黄埔区瑞祥路228号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy